Together, they are furthering NuView Life Science’s mission: to change the way many types of cancer are diagnosed and treated using precision medicine technology. Diagnosing and treating cancer with a targeted, specific approach to the disease will help to increase positive patient outcomes while also driving down costs incurred by patients, healthcare providers, and third-party insurance payers.
Meet Our Management Team
Mr. Davis has worked with a wide variety of clients in the areas of corporate, securities and business law since 1992 and has been responsible for over $1 billion in transactions. He is also on the Board of Directors of Theragene Pharmaceuticals, Inc. and Philter Labs, Inc., and was on the Board of Directors and Audit, Compensation, Nominating Committees (Chairman) and Special Committee (Chairman) of Telanetix, Inc., a publicly traded telecommunications company which was sold to InterMedia (an Oak Hill Capital portfolio company). He served as General Counsel and an executive officer of Molecular Imaging Corporation, a publicly traded healthcare company, and as in-house counsel for Leap Wireless International, a publicly traded wireless carrier. He also practiced in the Business and Corporate Group in the San Diego office of Luce, Forward, Hamilton & Scripps LLP (now Dentons), a large full-service law firm, where he advised both private and public clients in a variety of transactions.
Mr. Davis is licensed to practice law in California, the District of Columbia, and Minnesota. He received his Juris Doctor, Cum Laude, from the University of San Diego, School of Law in 1992. He received his B.A. in Political Science, Cum Laude, from Arizona State University in 1988.
He has also co-founded Clonatec, one of the first French biotech companies.